financetom
Business
financetom
/
Business
/
Ingredion Insider Sold Shares Worth $1,033,538, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ingredion Insider Sold Shares Worth $1,033,538, According to a Recent SEC Filing
May 14, 2024 9:21 AM

11:52 AM EDT, 05/14/2024 (MT Newswires) -- James D Gray, Executive Vice President and CFO, on May 13, 2024, sold 8,490 shares in Ingredion ( INGR ) for $1,033,538. Following the Form 4 filing with the SEC, Gray has control over a total of 42,833 shares of the company, with 42,833 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1046257/000112760224015193/xslF345X03/form4.xml

Price: 118.68, Change: -2.69, Percent Change: -2.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AI Infrastructure Acquisition Corp. to Ring the NYSE Opening Bell
AI Infrastructure Acquisition Corp. to Ring the NYSE Opening Bell
Nov 19, 2025
LAS VEGAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- AI Infrastructure Acquisition Corp. (the “Company”) , a newly organized blank check company incorporated as a Cayman Islands exempted company and led by Chief Executive Officer Michael Winston, announced today that it is celebrating its October 2025 initial public offering by ringing the New York Stock Exchange (“NYSE”) Opening Bell. The NYSE Opening Bell...
EyePoint Gets Positive Recommendation for Wet AMD Trials From Safety Committee
EyePoint Gets Positive Recommendation for Wet AMD Trials From Safety Committee
Nov 19, 2025
08:29 AM EST, 11/19/2025 (MT Newswires) -- EyePoint Pharmaceuticals ( EYPT ) said Wednesday that an independent Data Safety Monitoring Committee has recommended that its ongoing pivotal phase 3 program evaluating Duravyu for the treatment of wet age-related macular degeneration continue as planned without any modifications to the protocol. Topline data from the trials is expected starting in mid-2026, the...
BRIEF-Pantages Capital Acquisition Announces Business Combination With MacMines Austasia
BRIEF-Pantages Capital Acquisition Announces Business Combination With MacMines Austasia
Nov 19, 2025
Nov 19 (Reuters) - Pantages Capital Acquisition Corp ( PGAC ) : * PANTAGES CAPITAL ACQUISITION CORPORATION ANNOUNCES BUSINESS COMBINATION WITH MACMINES AUSTASIA PTY LTD. * PANTAGES CAPITAL ACQUISITION CORP ( PGAC ) -TRANSACTION VALUES TARGET AT USD$180 MILLION * PANTAGES CAPITAL ACQUISITION CORP ( PGAC ): UPON CLOSING OF DEAL, SHARES OF COMBINED COMPANY ARE EXPECTED TO TRADE ON...
Nanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S. Rollout of AI Solutions
Nanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S. Rollout of AI Solutions
Nov 19, 2025
PETACH TIKVA, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ( NNOX ) , an innovative medical imaging technology company, today announced that the parties have agreed on the terms and conditions pursuant to which Nanox will acquire VasoHealthcare IT Inc. (“VHC IT”) from Vaso Corporation (“Vaso”) , subject to certain conditions. This transaction is intended to accelerate...
Copyright 2023-2026 - www.financetom.com All Rights Reserved